Trials
Search / Trial NCT05638230

Relative Importance of Cardiovascular Risk Factors and Echocardiographic Parameters Affecting Left Atrial Strain

Launched by YONSEI UNIVERSITY · Nov 26, 2022

Trial Information

Current as of January 17, 2025

Recruiting

Keywords

Left Atrial Reservoir Strain Hfa Peff La Strain Heart Failure With Preserved Ejection Fraction (H Fp Ef)

ClinConnect Summary

This clinical trial is studying a specific measurement called left atrial reservoir strain (LARS) in people who have heart failure with preserved ejection fraction (HFpEF). The researchers want to find out if LARS can help predict the severity of heart failure and how it compares to other traditional risk factors, like blood pressure and cholesterol levels. They hope to better understand how different factors affect heart health, especially for patients with this type of heart failure.

To participate, you need to be at least 20 years old and have a diagnosis of heart failure. However, if you have certain heart conditions, such as a low ejection fraction (less than 50%) or specific heart rhythm issues, you won't be eligible. If you join the study, expect to have your left atrial reservoir strain measured, which is a relatively simple test that helps assess how well your heart is functioning. The trial is currently looking for participants and is open to all genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants with ICD-10 code of heart failure (I50) from August 2021 to July 2022
  • 20-year-old or higher age
  • Participants who are available to measure left atrial reservoir strain
  • Exclusion Criteria:
  • Left ventricular ejection fraction \<50%
  • Supraventricular arrhythmia (e.g. atrial flutter/fibrillation, atrial tachycardia)
  • Participants who are given pacemaker or ICD implantation procedure

About Yonsei University

Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.

Locations

Yongin, Gyeonggi, Korea, Republic Of

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials